Evidence Hub

Migraine diagnosis and pathophysiology

Ward TN

Continuum (Minneapolis, Minn.), 2012

Abstract

PURPOSE OF REVIEW: This article describes current knowledge regarding headache, especially migraine, and includes information on genetics, anatomy, pathophysiology, and pharmacology in order to demonstrate their relevance to clinical phenomenology.

RECENT FINDINGS: Animal models show that drugs effective in migraine prevention may work by raising the threshold for initiating cortical spreading depression and may also attenuate the response to simulation.

SUMMARY: Great advances have been made in diagnosing and understanding migraine over the past several decades. Tools such as the International Classification of Headache Disorders assist in making diagnoses. Although blood vessel changes do occur in migraine, they are not timelocked to the occurrence of head pain. Cortical spreading depression is at least one trigger for the events that occur in migraine. Migraine may be due to the interplay of host susceptibility and various triggers. Nitric oxide and calcitonin gene-related peptide are important mediators, and estrogen seems to "ramp up" the system.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free